Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN102612507A reveals a diimine hydrogenation process for artemisinin intermediates, offering cost reduction and high stereoselectivity for pharmaceutical manufacturing.
Patent CN101180263B reveals a novel 3-step synthesis eliminating dimer impurities. Discover cost-effective manufacturing and stable salt forms for neurodegenerative disease therapeutics.
Patent CN110305025B details a green photocatalytic method for benzylamine synthesis using Eosin Y and water, offering significant cost and safety advantages for pharmaceutical intermediates.